Literature DB >> 3954333

Observations on wet weight, protein and DNA as reference for steroid receptors in malignant mammary tumours.

A Norgren, M Fernö, A Borg.   

Abstract

Estradiol and progesterone receptors were recorded together with DNA and soluble protein per unit wet weight for 235 breast cancer samples. Receptor concentration values per wet weight showed the greatest range of variation. Receptor expressed per unit wet weight, DNA or protein showed good correlation (rs greater than 0.90). In selected cases different information on receptor concentration levels may be obtained depending on the reference parameter used. An overrepresentation was found of tumours with low receptor concentrations or receptors below the level of detection in a subgroup with a low DNA content, indicating the possibility of false low receptor values in this group. High ER and PgR contents were significantly related to high level of tissue DNA. Low or high content of protein was not associated directly with low or high receptor levels. In this respect DNA is superior to wet weight and protein as reference standards for receptor concentration. Further, DNA offers the additional possibility of a rough correction for non-epithelial components of the tumours. A critical dilution of receptors, as shown by low DNA content in some homogenates, was not apparent but cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954333

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Quantification of oestrogen receptors in breast cancer: radiochemical assay on cytosols and cryostat sections compared with semiquantitative immunocytochemical analysis.

Authors:  H M Scheres; A F De Goeij; M J Rousch; G G Hondius; D D Willebrand; A H Gijzen; F T Bosman
Journal:  J Clin Pathol       Date:  1988-06       Impact factor: 3.411

2.  Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?

Authors:  B Linderholm; B Tavelin; K Grankvist; R Henriksson
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.